0001209191-18-051909.txt : 20180921
0001209191-18-051909.hdr.sgml : 20180921
20180921165311
ACCESSION NUMBER: 0001209191-18-051909
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180920
FILED AS OF DATE: 20180921
DATE AS OF CHANGE: 20180921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOYES JAY M
CENTRAL INDEX KEY: 0001191062
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 033-80623
FILM NUMBER: 181082030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC.
CENTRAL INDEX KEY: 0000949858
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 954343413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 PIKE STREET
STREET 2: SUITE 2250
CITY: SEATTLE
STATE: WA
ZIP: 98101
BUSINESS PHONE: 425-686-1500
MAIL ADDRESS:
STREET 1: 520 PIKE STREET
STREET 2: SUITE 2250
CITY: SEATTLE
STATE: WA
ZIP: 98101
FORMER COMPANY:
FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20080821
FORMER COMPANY:
FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950825
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-20
0
0000949858
ACHIEVE LIFE SCIENCES, INC.
ACHV
0001191062
MOYES JAY M
520 PIKE STREET
SUITE 2250
SEATTLE
WA
98101
1
0
0
0
Stock Option (right to buy)
2.56
2018-09-20
4
A
0
12000
0.00
A
2028-09-20
Common Stock
12000
12000
D
The options vest in monthly installments over one year commencing one month from September 20 2018.
Sandra Thomson Attorney-in-fact for Jay Moyes
2018-09-21